MARKET

GNFTF

GNFTF

Genfit S A
EXMKT
16.50
NaN%
Closed 09:30 09/09 EDT
OPEN
--
PREV CLOSE
10.99
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
16.50
52 WEEK LOW
4.140
MARKET CAP
825.40M
P/E (TTM)
-8.1514
1D
5D
1M
3M
1Y
5Y
1D
Genfit Targets Billion‑Dollar MASH Diagnostics Market With NISTM Blood Tests
TipRanks · 1d ago
Genfit Targets Non‑Invasive MASH Diagnostics Growth After U.S. Reimbursement Win for NASHnext
TipRanks · 6d ago
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
Seeking Alpha · 08/10 13:16
Analysts Are Bullish on Top Healthcare Stocks: Genfit (GNFTF), Cogstate Ltd (COGZF)
TipRanks · 04/09 01:40
Genfit Receives FDA Orphan Drug Designation For NTZ In Acute-on-Chronic Liver Failure
NASDAQ · 03/10 03:32
Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Genfit (OtherGNFTF)
TipRanks · 03/01 19:10
Time To Take Profits On Gilead Sciences (Rating Downgrade)
Seeking Alpha · 02/20 19:24
Analysts’ Top Healthcare Picks: Genfit (GNFTF), Nyxoah (NYXH)
TipRanks · 02/15 01:40
More
About GNFTF
Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.

Webull offers Genfit SA stock information, including EXMKT: GNFTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNFTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNFTF stock methods without spending real money on the virtual paper trading platform.